Vitreous Hemorrhage

Search with Google Search with Bing
Information
Disease name
Vitreous Hemorrhage
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06383754 Completed N/A Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study June 7, 2021 March 15, 2024
NCT00000162 Completed Phase 3 Branch Vein Occlusion Study July 1977
NCT00155454 Completed N/A Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy September 2004 December 2012
NCT00198497 Completed Phase 3 Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage June 1999 June 2003
NCT00198510 Completed Phase 3 Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage November 1998 March 2003
NCT00411970 Completed Phase 4 20- Versus 23- Gauge System for Pars Plana Vitrectomy September 2004 October 2007
NCT00596297 Completed Phase 1/Phase 2 Preoperative Bevacizumab for Vitreous Hemorrhage November 2007 September 2008
NCT00745498 Completed N/A Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy June 2008 October 2010
NCT00996437 Completed Phase 2/Phase 3 Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) June 2010 January 2013
NCT01724385 Completed Phase 4 Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy August 2012 December 2012
NCT01805297 Completed Phase 2 Aflibercept Injection for Proliferative Diabetic Retinopathy March 2013 November 2015
NCT01854593 Completed Phase 4 Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy May 2012 March 2014
NCT02151305 Completed N/A Different Hemostasis According to the Anesthetic Agents August 2010 April 2012
NCT02858076 Completed Phase 2/Phase 3 Anti-VEGF vs. Prompt Vitrectomy for VH From PDR November 2016 January 2020
NCT04712786 Completed Refractive Changes Following Vitrectomy December 1, 2020 December 27, 2020
NCT04859556 Completed N/A Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study May 1, 2018 June 1, 2020
NCT05710458 Completed N/A Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter July 1, 2021 November 30, 2022
NCT00000154 Completed Phase 3 Diabetic Retinopathy Vitrectomy Study (DRVS) October 1976
NCT06343961 Not yet recruiting N/A Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy April 18, 2024 December 2025
NCT05514925 Recruiting Phase 4 Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy November 21, 2017 December 31, 2022
NCT05529589 Recruiting Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting Membrane February 10, 2023 October 30, 2023
NCT05588037 Recruiting N/A Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery January 1, 2017 December 31, 2023
NCT04346095 Unknown status Phase 4 Oral Sedation in Vitreoretinal Surgery June 2020 November 2020
NCT04404296 Unknown status N/A Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter April 1, 2021 January 30, 2022
NCT01824043 Unknown status Phase 4 Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage March 2013 December 2013
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0007902
MeSH unique ID (MeSH (Medical Subject Headings))
D014823